Amo Pharma Ltd Is A Biopharmaceutical Company Dedicated To Developing Treatments For Serious Diseasesparticularly Rare Genetic Disordersfounded In February 2015The Company Operates Internationallywith Leadership Based In The U Sand U Kamo Pharma Focuses On Understanding Unmet Medical Needs And Patient Experiences To Guide Its Therapy Developmentaiming To Improve Clinical Outcomes And Quality Of Life The Company Is Advancing Several Clinical Stage Investigational Drugs Targeting Neuromuscular And Cns Symptoms Of Rare Diseasesnotable Products Include Amo 01 For Phelan Mcdermid Syndromeamo 02Tideglusibfor Congenital Myotonic Dystrophy Type 1And Amo 04 For Rett Syndromeamo Pharma Emphasizes Collaborative Drug Developmentengaging With Patientsresearchersand Physicians To Refine Trial Protocols And Ensure Regulatory Complianceas A Privately Held Companyit Leverages International Resources For Clinical Trials And Partnerships
